Skip to content

Shock Wave Versus Iontophoresis in Treatment of Subjects With Knee Osteoarthritis

Effect of Extra Corporeal Shock Wave Versus Dexamethasone Iontophoresis in Treatment of Knee Osteoarthritis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04731350
Acronym
Shockwave
Enrollment
60
Registered
2021-01-29
Start date
2021-01-20
Completion date
2023-01-15
Last updated
2023-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Brief summary

Both extra corporeal shock wave and dexamethasone iontophoresisare effective in treatment of knee osteoarthritis but which one is more effective is not clear yet . so the purpose of this study was to investigate and compare between the effect of shock wave and iontophoresis in treatment of knee osteoarthritis . it was hypothesized that there will be no difference between the effect of shock wave and iontophoresis on treatment of knee osteoarthritis.

Detailed description

60 subjects with grade II knee osteoarthritis will be recruited from outpatient clinic of faculty of physical therapy and then they will be assigned randomly by sealed envelope into three groups ;group A (shock wave group) will received radial extracorporeal shock wave ,group B (Iontophoresis group ) will receive deaxamthasone iontophoresis and group c (control group) will receive traditional tratment ( stregnthening exerciseces) all treatment will be once session per week for four weeks .pain intensity ,knee ROM and knee injury and osteoarthritis outcome score physical function short (KOOS-PS).

Interventions

Radial shock wave device, Swiss DolorClast (EMS Electro Medical Systems, Nyon, Switzerland)

Iontophoretic drug delivery system (phoresors II auto model PM850 IOMED):

OTHERExercise

strengthening exercise

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
40 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

1. Symptomatic knee OA for at least 3 months according to clinical criteria of American College of Rheumatology 2. Radiologic findings had to be compatible with knee OA, with kelgren and Lawrence (K-L) grade 2 in a simple X ray . 3. Tenderness on medial tibial plateau 4. Intensity of pain: visual analogue scale equal to 5 or greater 5. Failure of two or more types of previous conservative treatment (medication, anti-inflammatory drugs, physical therapy, stretching, acupuncture, orthotics and others)

Exclusion criteria

1. Neuorological and vestibular system disorder, systematic inflammatory disease, steroid injections in the last six months 2. Any contraindication to magnetic resonance imaging or radiography, or trauma history on knee 3. history of previous knee surgery -

Design outcomes

Primary

MeasureTime frameDescription
visual analogue scale (VAS)change from baseline to immediately pre treatment and from pre treatment to immediately post treatmentpain intensity will be assessed by using visual analogue scale

Secondary

MeasureTime frameDescription
knee range of motion (ROM)change from baseline to immediately pre treatment and from pre treatment to immediately post treatmentelectronic geniometer
knee injury and osteoarthritis outcome score physical function short (KOOS-PS)change from baseline to immediately pre treatment and from pre treatment to immediately post treatmentknee function by using KOOS-PS questionnaire

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026